Molecular Therapy

Molecular Therapy Family's Impact Factor Increased 44 Percent in 2020

ASGCT Staff - July 01, 2021

Molecular Therapy-Oncolytics' 75% increase, to 7.200, was the highest impact factor jump across more than 50 Cell Press journals.

Impact factor scores for the Molecular Therapy family of journals, the official journals of the American Society of Gene & Cell Therapy (ASGCT), rose by a collective average of 44 percent in 2020.

Impact factors, which measure the frequency with which an average article has been cited in a journal, rank research titles against one another to determine leading journals around the world.

Overall growth in the Molecular Therapy family of journals is as follows:

  • Molecular Therapy: 11.454 (+27 percent)
    • Ranked 11/140 in the category of medicine, research, and experimental and 6/159 in the category of biotechnology and applied microbiology
    • Received 24,333 citations in 2020
  • Molecular Therapy-Nucleic Acids: 8.886 (+26 percent)
    • Ranked 13/140 in medicine, research, and experimental
    • Received 8,812 citations in 2020
  • Molecular Therapy-Oncolytics: 7.200 (+75 percent)
    • Ranked 20/140 in medicine, research, and experimental and 44/242 in oncology
    • Received 1,582 citations in 2020
    • Highest percent increase across more than 50 journals from publisher Cell Press
  • Molecular Therapy-Methods & Clinical Development: 6.698 (+48 percent)
    • Ranked 25/140 in medicine, research, and experimental
    • Received 3,268 citations in 2020

 

Share This Page

Related Articles

Molecular Therapy

Meet the Editor: Gerhard Bauer, Molecular Therapy—Methods & Clinical Development

ASGCT Staff - November 25, 2019

ASGCT member and Indiana University professor of pediatrics Roland W. Herzog, Ph.D. will become the editor-in-chief of ASGCT's field-leading journal, Molecular Therapy, on January 1, 2020.

Molecular Therapy

Meet the Editor: Roland W. Herzog, Ph.D., Editor-in-Chief of Molecular Therapy

ASGCT Staff - November 25, 2019

Herzog and Bauer will assume their roles as editors-in-chief of ASGCT’s Molecular Therapy and Molecular Therapy—Methods & Clinical Development, respectively, on January 1.

Molecular Therapy

Molecular Therapy Family of Journals Welcomes Two Editors-in-Chief

ASGCT Staff - November 25, 2019
Molecular Therapy

A New AAV Vector Can Efficiently Target the Brains of Mice Through IV Injection

Killian S. Hanlon, Eloise Hudry, and Casey A. Maguire - November 22, 2019